Ray Dalio started to build up the position in Burning Rock Biotech Ltd in Q2 2021 and continued to invest until Q4 2021. Since then they sold 19.4k shares. The investor completely sold their stake between Q1 2022 and Q3 2023.
Avg closing price
Price range
Sold -1.68k shares
Q3 2023
Avg closing price
$1.56
Price range
$0.91
-
$2.29
Sold 74.2% shares (-4.81k shares)
Q2 2023
Avg closing price
$2.65
Price range
$2.15
-
$3.16
Sold 24.0% shares (-2.05k shares)
Q1 2023
Avg closing price
$3.00
Price range
$2.16
-
$3.47
Sold 1.6% shares (-142 shares)
Q4 2022
Avg closing price
$2.28
Price range
$1.73
-
$2.95
Sold 3.3% shares (-297 shares)
Q3 2022
Avg closing price
$3.23
Price range
$2.39
-
$3.96
Sold 43.4% shares (-6.87k shares)
Q2 2022
Avg closing price
$4.47
Price range
$1.75
-
$10.44
Sold 18.2% shares (-3.52k shares)
Q1 2022
Avg closing price
$8.69
Price range
$6.70
-
$10.23
Increased shares by 22.4% (+3.54k shares)
Q4 2021
Avg closing price
$13.70
Price range
$9.43
-
$17.14
Increased shares by 365.9% (+12.4k shares)
Q3 2021